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Abstract. Raman data from human fingernails has been analysed to determine if a relationship exists between spectral features
and bone quality. Previous work demonstrated a relationship between the manually determined intensity of the disulphide peak
(Bone Quality Test; BQT) and osteoporotic fracture. A computer program is now described that automates the BQT determi-
nation for large sample-sets. In this study the ability of the automated BQT to discriminate between fractures and controls was
compared to that of bone mineral density (BMD) and biomarkers of bone remodelling. Females aged 18–67 years participated
in the study (n = 159). Fingernails were analysed using Raman spectroscopy. Lumbar and Femoral BMD was measured by
dual energy X-ray absorptiometry (DXA). Fasting venepuncture samples were analysed for osteocalcin and CTx (collagen
C-telopeptides) by electrochemiluminescence. No correlation was found between the BQT and BMD or the biomarkers. The
BQT and BMD were found to be equally accurate in identifying subjects with a history of fracture (p < 0.01) and both outper-
formed osteocalcin and CTx. It appears that keratin and collagen are related structural proteins that require disulphide bonding
for stability. Therefore, these preliminary results suggest that Raman spectroscopy of keratin may have potential as a diagnostic
tool for screening bone quality in large populations.
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1. Introduction
Raman spectroscopy is a promising tool for evaluation of bone quality and fracture risk [11,18,19].
The spectroscopic parameters related to bone quality are mineral content, mineral crystallinity and col-
lagen cross-link ratio [21]. Raman analysis of iliac crest biopsies has revealed bone tissue compositional
differences in women with and without osteoporotic fracture. Fracture cases were reported to have a
higher carbonate/amide I area ratio than controls in femoral trabecular samples and a higher carbon-
ate/phosphate ratio in cortical bone samples [19], which was in agreement with previous results from
infrared spectroscopy studies [6].
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Raman spectroscopy of nail samples has previously proved successful in archaeological [12] and
forensic investigations [1,30]. The composition of finger and toe nail samples are influenced by several
physiological and pathological processes [27]. Fingernails have recently been identified as a biomarker
for esophageal cancer using infrared spectroscopy [28].
Anecdotally, osteoporosis patients have reported increased fingernail strength following pharmaceuti-
cal treatment [16]. Preliminary work by the authors has evaluated the use of Raman spectroscopy to in-
vestigate the link between fingernail protein structure (keratin) and bone protein structure (collagen) [20,
24,26]. Both proteins require cysteine incorporation and sulphation for structural integrity. The biosyn-
thesis of procollagen requires both intra- and inter-chain disulphide bond formation [7]. Noncollagenous
proteins in the organic matrix such as osteonectin also require disulphide bonding for stability [5]. It was
recently reported that postmenopausal women with osteoporosis have elevated total homocysteine (Hcy)
and significantly reduced plasma cysteine (Cys) levels in comparison to their healthy counterparts [4].
The inverse relationship between total Hcy and Cys might imply that a trans-sulphuration defect could
be impairing the irreversible conversion of total Hcy to Cys. The authors suggest that a low Cys con-
centration, possibly due to reduced flux from Hcy, may lead to less availability for collagen formation
resulting in poor bone quality [4].
Changes in the organic matrix, or in the collagen molecule alone, have been observed in osteoporosis
[3]. Bone strength therefore reflects the integration of two main features, bone density and bone quality
[22]. Bone quality refers, in part, to the organic matrix of bone but also describes a set of characteristics
that influence strength such as architecture, remodelling and damage accumulation [22]. Measurement of
bone density by dual energy X-ray absorptiometry (DXA) is the current gold standard for the diagnosis
of osteoporosis. However, DXA is not adequate for population screening due to cost constraints and
availability. More importantly, DXA is limited in its ability to detect individuals who will fracture [23]
as subjects with normal bone density can suffer fragility fractures due to factors independent of BMD,
for example bone remodelling rate [14]. Biochemical markers of bone remodelling can be used as a
measure of bone quality and have been reported to predict bone loss [8] and future fracture risk [14].
These markers have the advantage of being non-invasive and also respond more quickly to intervention
than densitometry [29].
Significantly lower disulphide content of fingernails have been observed in subjects with a history of
low-impact fracture, using the Raman spectroscopy based Bone Quality Test (BQT) [20,26]. Therefore,
the aim of this study is to further investigate the validity of Raman spectroscopy as a tool in the assess-
ment of bone health and to compare its efficacy with the other techniques currently available in clinical
practice.
2. Experimental
2.1. Study design and patient population
With ethical approval and informed consent, 159 eligible females (18–67 years) participated in this
cross-sectional study. Subjects were recruited by posters, email and word of mouth at the university
campus and from the surrounding area. Prior to enrolment, subjects completed a questionnaire detail-
ing medical and fracture history. A low-impact fracture was defined as a fracture resulting from a fall
of standing height or less. Post-menopausal status was defined by duration of greater than 18 months
post-menopause. Subjects were excluded from the study on the basis of medical conditions (other than
primary osteoporosis) or treatment (bone active medication) that may affect bone or fingernail health.
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2.2. Collection of nail samples
Two nail clippings were taken from each subject from the free edge of the nail plate and stored in
sealed microtubes. Samples were swabbed with acetone (Reagecon, Shannon, Ireland) to remove any
traces of nail varnish prior to analysis.
2.3. Raman spectroscopy
Raman analysis (Inspector Raman Instrument, Delta Nu, WY, USA) was performed on the under-
side of the fingernail. Excitation was by diode laser operating at 785 nm. Spectra were recorded (400–
1800 cm−1; Fig. 1) by securing the nail to the analysis port and performing ten scans, each with a
laser exposure time of 5 s, to improve the signal-to-noise ratio. The average of ten scans was taken as
one determination. Two determinations were performed upon each of the two nails. In previous work the
intensity of S–S bonding in the sample (Bone Quality Test; BQT) was evaluated manually [20,26]. How-
ever, manual determination of peak intensity may be influenced by the subjective assessment of the peak
base, especially for spectra with varying background shapes. To preclude this, and to facilitate efficient
analysis of larger data sets, a computer program was written to automate the methodology (Dr. John
Day, Interface Analysis Centre, University of Bristol, UK). The program, written in Borland Delphi 7,
allowed the import of a large number of spectra obtained from patients divided into control and fracture
groups. The program initially normalized spectra to obtain a constant total intensity and averaged spectra
for each patient before implementing a method for the determination of S–S peak width.
The background in Raman spectra is dominated by fluorescence and it was evident that this was highly
variable between different samples. The peak width measurement is affected by parameters other than
signal intensity. Raman peak width is dependent on variations in the length of the active bond, which
may be due to strain or structural broadening caused by variations in the local crystal order [9]. A method
of peak width determination based on the derivative spectra was implemented. In this the first derivative
Fig. 1. Raman spectrum of a human fingernail 400–1800 cm−1.
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of the spectrum was calculated. The maximum and minimum derivative values were then found on either
side of the S–S peak at 510 cm−1. These correspond to the points of steepest slope about the peak centre.
The distance between these two points was used as a measure of peak width. The derivative calculation
was made either as a simple arithmetic difference between consecutive points or by applying a Savitsky–
Golay smoothing filter to the data. Therefore, in this study the BQT was calculated as the width of the
S–S peak at 510 cm−1 for each sample.
2.4. Bone densitometry
Lumbar and Femoral BMD was measured by DXA (Norland Medical Systems, NY, USA) with strict
adherence to recommended quality assurance practice.
2.5. Biochemical markers of bone remodelling
Single venepuncture samples were collected from fasting subjects and serum was analysed for bone
formation (N-MID® Osteocalcin) and resorption (β-CTx crosslaps) markers by electrochemilumines-
cence (Elecsys 1010, Roche, Basel, Switzerland). All values were within the reference ranges reported
by the manufacturer and the coefficient of variation was 4% for osteocalcin and 5% for CTx.
2.6. Calcium intake
A food frequency questionnaire was used to assess calcium (Ca) intake in the population. This method
has previously been reported to correlate well (r = 0.79) with the gold standard weighed food record [2].
2.7. Data analysis
Statistical analysis was performed using SPSS software (Microsoft, CA, USA). Variables were tested
for normality using the Kolmogorov–Smirnov test. Depending on the normality of the distribution, Pear-
sons or Spearmans correlation coefficients were calculated to examine the relationship between the clin-
ical tools. Comparisons between parameters in the fracture and control groups were performed by the
Student’s t-test or the Mann–Whitney test (MWU) as appropriate.
3. Results and discussion
The study population comprised 159 women of whom 81 were pre-menopausal and 78 were post-
menopausal. A total of 34 fracture cases were recorded with 16 occurring in the pre-menopausal women
and 18 occurring in the post-menopausal women. Menopausal status did not significantly influence BQT
(p = 0.062), therefore further analysis was performed on the total group of 159 subjects in order to
improve the power of the study. Fractures were recorded in subjects who had normal BMD, osteopenia
and osteoporosis, with wrist, ankle and arm fractures being most common. The BQT was slightly higher
in the high-impact fractures (n = 26) than in the low-impact fractures (n = 8) although this did not
reach significance (37.37 vs. 35.57, respectively, p = 0.749).
No significant difference in age (p = 0.829), calcium intake (p = 0.504) or BMI (p = 0.855) was
observed between the control and fracture groups (Table 1). There was a higher prevalence of smokers
in the fracture group (n = 8, 24%) than in the control group (n = 17, 14%). Smokers had significantly
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Table 1
Study group characteristics
Total group (n = 159) Control group (n = 125) Fracture group (n = 34)
Mean age (SD) (years) 45 (15) 46 (15) 44 (17)
Mean Ca (SD) (mg/d) 814 (368) 807 (369) 840 (370)
Mean BMI (SD) (kg/m2) 25.19 (3.88) 25.31 (4.10) 24.72 (2.91)
Current smokers (number) n = 25 n = 17 n = 8
Family history ost. (number*) n = 43 n = 29 n = 14
Note: *Number of participating subjects with a family history of osteoporosis.
Table 2
Student’s t-test and Mann–Whitney results for bone health measures in control and fracture groups
Control group n = 125 Fracture group n = 34 Significance
Mean Lumbar BMD (SD) (g/cm2) 1.032 (0.165) 0.947 (0.172) p = 0.009
Mean Femoral BMD (SD) (g/cm2) 0.877 (0.133) 0.829 (0.141) p = 0.071
Mean BQT (SD) (a.u.) 45.02 (13.75) 36.94 (13.56) p = 0.003
Median* Osteocalcin (SD) (ng/ml) 27.22 (11.12) 27.62 (11.25) p = 0.735
Median* CTx (SD) (ng/ml) 0.423 (0.216) 0.433 (0.228) p = 0.617
Note: *Data non-normally distributed therefore median value from MWU presented.
lower Lumbar BMD than non-smokers (0.938 vs. 1.028, p = 0.015) and Femoral BMD approached
significance (p = 0.058). Similar findings were recently reported by Demirbag et al. in 2006 [10].
Smoking did not appear to influence disulphide levels in fingernails (p = 0.340). The relationship
between cysteine, homocysteine and smoking currently remains unclear in the literature and requires
further investigation [17,25]. There was no significant difference between smokers and non-smokers in
serum levels of osteocalcin and CTx.
Significantly lower disulphide content of fingernails was again observed in subjects with a history of
fracture and this is in agreement with previous studies [20,24]. In comparison to the other methods used
in this study the BQT discriminated most accurately between the control and fracture cases (p = 0.003;
Table 2).
Disulphide bonding is essential for procollagen folding and stability of mature collagen [7]. These pre-
liminary results suggest that nail keratin may be a suitable analogue for bone collagen. In this study, the
BQT performed comparably with DXA (Lumbar BMD, p = 0.009) which is the current gold standard
for diagnosis of osteoporosis. This is in agreement with a previous study which suggests that BQT and
BMD are equivalent predictors of fracture status (BQT odds ratio 0.188 vs. BMD 0.282, p < 0.0005)
[26]. DXA evaluates the mineral phase of bone. There does not appear to be any relationship between
DXA and the BQT (Lumbar BMD, R = −0.121, p = 0.130; Fig. 2), despite both techniques being
comparable in their ability to identify subjects with a history of fracture. This is likely due to the com-
posite nature of bone because fracture risk depends on the health of both the organic and mineral phases
which are evaluated separately by the two different techniques.
Biochemical markers of bone remodelling can be used to evaluate the organic phase of bone [8,14].
However, in this study, biomarkers did not prove to be useful in distinguishing between the fracture and
control groups (Osteocalcin, p = 0.735, CTx, p = 0.617). This could be due to the fact that single
samples were analysed in this study and these biomarkers express a high level of biological variability.
Seasonal and diurnal rhythms exist and biomarkers are known to be influenced by exercise, bed-rest
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Fig. 2. Correlation of the BQT with Lumbar BMD and CTx (n = 159).
and extremes of diet [29]. There was no correlation between the biomarkers and the BQT (e.g., CTx,
R = −0.079, p = 0.325; Fig. 2) which could be attributed to the previously discussed single sam-
ple variability. It is possible that there may not be a relationship between osteocalcin and CTx and the
disulphide levels of keratin, because of the bone characteristics that the BQT is assessing, but a relation-
ship may exist with other biomarkers such as cathepsin K, an osteoclast-derived member of the cysteine
protease family that has the ability to cleave both helical and telopeptides regions of collagen [13].
There was also no relationship between the biomarkers and DXA in this study (e.g., osteocalcin vs.
Femoral BMD, R = 0.101, p = 0.204). This agrees with the literature as biochemical bone markers are
reported to contribute less than 10% to the BMD variance at any skeletal site among pre-menopausal
and early post-menopausal women [15].
One of the limitations of this study was the low number of fractures, particularly low-trauma fractures,
in the population. A further limitation was the retrospective, cross-sectional design and relatively small
sample size of the study. Based on the results obtained here it is hoped that a large-scale prospective
study will be conducted in the near future which will incorporate multivariate analysis of data. This will
allow the nail-bone relationship to be explored in depth by examining additional peaks in the Raman
spectrum of nail and bone such as the methylene band at 1450 cm−1 and the amide I band at 1650 cm−1.
Paired specimens of nail and bone from biopsies or an animal trial, may also help to shed light on the
physiological link between collagen and keratin.
The use of fingernails as a biomarker would have the advantage of greater stability over biochemical
markers of bone remodelling in serum or urine and also greater responsiveness than BMD as measured
by DXA, due to fingernail growth rates. The absence of ionising radiation, ease of use, portability of the
equipment and its cost effectiveness could make the BQT an attractive option for managing osteoporosis
in the future. With further development, it appears that the BQT may have potential for monitoring osteo-
porosis therapy, as a pre-screen for DXA, or in combination with DXA to assist in the early identification
of individuals who are at high risk of fracture.
4. Conclusions
Although further investigation is necessary, it appears that Raman spectroscopy of keratin may have
potential for evaluating bone quality and fracture risk. The advantages of examining nail lie in its ability
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to assess properties other than those measured by DXA, alongside its accessibility and its rapid turnover,
allowing change to be monitored on a more frequent basis.
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